199
Participants
Start Date
November 30, 2014
Primary Completion Date
June 30, 2028
Study Completion Date
June 30, 2028
Trabectedin
"Escalating or deescalating dose of 1.3 or 1.5mg/m2, i.v 24h, once every 3 weeks.~Cohort A: unlimited cycles. Cohort B: 3 cycles. Cohort C: 3 cycles. Cohort D: cycles of trabectedin will be provided and patients will subsequently be evaluated for surgery."
Radiotherapy
3D conformal radiotherapy (3D-CRT) or intensity modulated radiotherapy (IMRT) providing: Cohort A: 30Gy in 10 fractions (3Gy/fraction). Cohort B: 45Gy in 25 fractions (1.8Gy/fraction). Cohort C: 45Gy in 25 fractions (1.8Gy/fraction). Cohort D: 45Gy in 25 fractions (1.8Gy/fraction).
RECRUITING
Candiolo Cancer Institute, Candiolo
NOT_YET_RECRUITING
Istituto Clinico Humanitas, Rozzano
RECRUITING
Istituto Nazionale dei Tumori, Milan
RECRUITING
Hospital Puerta de Hierro, Madrid
RECRUITING
Hospital Universitario Gregorio Marañón, Madrid
RECRUITING
Hospital Uniersitario La Paz, Madrid
RECRUITING
Institut Bergonié, Bordeaux
NOT_YET_RECRUITING
Centro di Referimento Ocologico, Aviano
RECRUITING
Hospital Universitario Canarias, San Cristóbal de La Laguna
NOT_YET_RECRUITING
Istituto Ortopedico Rizzoli, Bologna
RECRUITING
Hospital Virgen del Rocío, Seville
RECRUITING
Hospital Miguel Servet, Zaragoza
RECRUITING
Centre Léon Berard, Lyon
RECRUITING
Jiménez Díaz Foundation University Hospital, Madrid
RECRUITING
Hospital Sant Pau, Barcelona
RECRUITING
Hospital Son Espases, Palma de Mallorca
RECRUITING
Hospital Vall d'Hebrón, Barcelona
Centre Leon Berard
OTHER
Italian Sarcoma Group
NETWORK
Grupo Espanol de Investigacion en Sarcomas
OTHER